Clinical Trials Directory

Trials / Completed

CompletedNCT03662893

Behavioural Therapy With Checklist for Overactive Bladder

Checklist to Increase Effectiveness of Behavioural Therapy for Overactive Bladder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Ankara Training and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate the efficiency of this newly-established checklist for overactive bladder (OAB) and whether determinate to adherence and persistence rate of combination of behavioural therapy and anticholinergic medications in patients with OAB.

Detailed description

Overactive bladder (OAB) can worsen quality of life but it is not life-threatening condition. Although OAB medications effectively decrease disturbing symptoms of OAB, there are a lot of adverse side effects such as dry mouth, cognitive changes, constipation, urinary retention, blurred vision and dyspepsia. Therefore, guidelines have firstly recommended behavioural therapy which are noninvasive and not linked with adverse side effects. These behavioural recommendations include an advice on fluid balance, bladder retraining, urgency suppression or normal voiding techniques, pelvic floor muscle training, caffeine reduction, dietary changes, weight loss and other life style changes to improve lower urinary tract symptoms of OAB. Educational leaflets, verbal or audio-visual instructions and trainings for behavioural therapy have been recommended for patients with OAB, however, to date these beneficial instructions have not been documented as a written checklist. Therefore, they were collected and developed as a written checklist to instruct the patients. The aim of this study was to investigate the efficiency of this newly-established checklist for OAB and whether determinate to adherence and persistence rate of combination of behavioural therapy and anticholinergic medications in patients with OAB.

Conditions

Interventions

TypeNameDescription
BEHAVIORALbehavioural therapy with written checklist form to completeBehavioural therapy for overactive bladder such as advice on fluid balance, bladder retraining, urgency suppression or normal voiding techniques, pelvic floor muscle training, caffeine reduction, dietary changes, weight loss and other life style changes
DRUGAntimuscarinic drugs used in overactive bladderAntimuscarinic drugs (Tolterodine, solifenacin, propiverine, darifenacin,fesoterodine)
BEHAVIORALbehavioural therapy with written guidelinebehavioural therapy with written guideline,which are the same as those in the checklist

Timeline

Start date
2015-01-01
Primary completion
2017-12-31
Completion
2018-04-15
First posted
2018-09-10
Last updated
2018-09-10

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03662893. Inclusion in this directory is not an endorsement.